Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection (LISHBV)
Liver Injury by Statins in Coronary Heart Disease (CHD) Patients With History of Hepatitis B Virus (HBV) Infection
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Listed as NCT02808299, this observational or N/A phase trial focuses on Hepatitis B Virus Infection History and Liver Injury and remains ongoing. Sponsored by The First Affiliated Hospital with Nanjing Medical University, it has been updated 5 times since 2016, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Apr 2018 — Jan 2021 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The First Affiliated Hospital with Nanjing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .